Statin effects on atherosclerotic plaques: regression or healing? (2015)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1186/s12916-015-0499-9
- Subjects: INIBIDORES DE ENZIMAS (EFEITOS ADVERSOS); MEDICAMENTO (ADMINISTRAÇÃO E DOSAGEM); CORONARIOPATIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: BMC Medicine
- ISSN: 1741-7015
- Volume/Número/Paginação/Ano: v. 13, 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BITTENCOURT, Márcio Sommer e CERCI, Rodrigo Julio. Statin effects on atherosclerotic plaques: regression or healing?. BMC Medicine, v. 13, 2015Tradução . . Disponível em: https://doi.org/10.1186/s12916-015-0499-9. Acesso em: 24 abr. 2024. -
APA
Bittencourt, M. S., & Cerci, R. J. (2015). Statin effects on atherosclerotic plaques: regression or healing? BMC Medicine, 13. doi:10.1186/s12916-015-0499-9 -
NLM
Bittencourt MS, Cerci RJ. Statin effects on atherosclerotic plaques: regression or healing? [Internet]. BMC Medicine. 2015 ; 13[citado 2024 abr. 24 ] Available from: https://doi.org/10.1186/s12916-015-0499-9 -
Vancouver
Bittencourt MS, Cerci RJ. Statin effects on atherosclerotic plaques: regression or healing? [Internet]. BMC Medicine. 2015 ; 13[citado 2024 abr. 24 ] Available from: https://doi.org/10.1186/s12916-015-0499-9 - Longitudinal changes in physical activity positively impact high sensitivity C-reactive protein levels
- Resting electrocardiographic variables of patients with severe coronary artery disease undergoing coronary artery bypass graft surgery plus intramyocardial bone marrow cell injection: an one-year follow up study
- Recurrent pulmonary edema caused by chronic left main coronary artery occlusion
- Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events
- Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists
- Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA)
- Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter]
- Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry
- Yield of different approaches for screening for cardiovascular disease in asymptomatic diabetics
- Costs and diagnostic yield of exercise treadmill testing vs. exercise SPECT in symptomatic patients at intermediate risk of CAD
Informações sobre o DOI: 10.1186/s12916-015-0499-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
